FANCL antibody
Quick Overview for FANCL antibody (ABIN5701881)
Target
See all FANCL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Immunogen
- Fanconi anemia, complementation group L
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
human brain tissue were subjected to SDS PAGE followed by western blot with FNab03010(FANCL antibody) at dilution of 1:300
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Alternative Name
- FANCL
-
Background
- Synonyms:PHF9 Background:The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity, they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group L. Alternative splicing results in two transcript variants encoding different isoforms.
-
Molecular Weight
- 41-43 kDa
-
Gene ID
- 55120
-
UniProt
- Q9NW38
-
Pathways
- DNA Damage Repair
Target
-